Evidence map›Paper›PMID 41709227›Full record

ArticleJournal of neuroinflammation2026

Inflammatory stimulus enhances synaptic material uptake by adult APP microglia in a microfluidic neuron-microglia co-culture model.

Dolores Siedlecki-Wullich, Anne-Marie Ayral, Lukas Iohan, Célia Lemeu, Valérie Buiche, Karine Blary, Julien Chapuis, Fanny Eysert, Delphine Beury, Myriam Delacre and 6 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dolores Siedlecki-WullichUniversité de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France. siedleckidolores@gmail.com.ORCID http://orcid.org/0000-0002-9099-9406
Anne-Marie AyralUniversité de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France.
Lukas IohanUniversité de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France.
Célia LemeuUniversité de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France.
Valérie BuicheUniversité de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France.
Karine BlaryUniv. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France, UMR 8520 - IEMN - Institut d'Electronique de Microélectronique et de Nanotechnologie, Lille, F-59000, France.
Julien ChapuisUniversité de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France.
Fanny EysertUniversité de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France.
Delphine BeuryUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, F-59000, France.
Myriam DelacreUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, F-59000, France.
David HotUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, F-59000, France.
Takahiro MasudaDivision of Molecular Neuroimmunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Klaus-Peter KnobelochInstitute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Marco PrinzInstitute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Jean-Charles Lambert *Université de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France.
Devrim Kilinc *Université de Lille, Institut Pasteur de Lille, CHU Lille, INSERM U1167, LabEx DISTALZ, Lille, 59019, France. devrim.kilinc@pasteur-lille.fr.ORCID http://orcid.org/0000-0003-3321-5203

Funding

Alzheimer's Association AARG-22-926152CURE:JPMXP1323015486 MIB; AMRCEU Joint Programme ̶ Neurodegenerative Disease Research (JPND) 3DMiniBrain; PMG-ADFrench Renatech network P-21-03626Japan Agency for Medical Research and Development JP23gm1910004; JP23jf0126004; JP24zf0127012JSPS KAKENHI JP25H01009; JP25K02573Sanofi i-Awards Europe 2019 196026
6 · The paper itself

Abstract

Microglia play a critical role in synapse remodeling and neuroinflammation, both of which are dysregulated in Alzheimer’s disease (AD). However, most in vitro models rely on neonatal or immortalized microglia, limiting their relevance to adult pathophysiological context. Here, we present a compartmentalized microfluidic co-culture platform that enables spatially controlled interactions between primary cortical neurons and adult microglia from wild-type (WT) and APP-transgenic mice. This system allows precise functional analysis of microglia–synapse interactions under defined inflammatory conditions. Upon lipopolysaccharide (LPS) stimulation, APP microglia exhibited exaggerated morphological responses, elevated IL-1β secretion, and selectively increased uptake of synaptic material. In contrast, internalization of non-specific substrates such as pHrodo™ Zymosan remained unchanged, suggesting substrate-specific microglial responses. Blocking the complement receptor CD11b abolished the LPS-induced increase in synaptic uptake, confirming the role of complement-dependent pathways. Transcriptomic profiling revealed robust inflammatory responses in both genotypes, with genotype-dependent differences in proinflammatory gene expression, consistent with a primed immune phenotype. Importantly, increased synaptic uptake occurred without measurable loss of global synaptic connectivity, highlighting the ability of the system to detect microglial functional changes. This model captures genotype-dependent microglial reactivity under inflammatory stimulus and provides a physiologically relevant, tractable in vitro platform for dissecting microglial contributions to synaptic vulnerability under inflammatory conditions relevant to neurodegenerative diseases.

Indexed as

Amyloid beta-Protein PrecursorInflammationMicrogliaNeuronsSynapsesAnimalsCells, CulturedCoculture TechniquesLipopolysaccharidesMiceMice, Inbred C57BLMice, TransgenicMicrofluidicsAmyloid beta-Protein PrecursorLipopolysaccharidesAlzheimer’s diseaseAPP mouse modelIL-1βmicrofluidicsmicroglianeuroinflammationPSD95synapse

Identifiers

PMID41709227
PMCPMC12937550

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.